| __timestamp | Blueprint Medicines Corporation | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 7890000 | 31073000 |
| Thursday, January 1, 2015 | 14456000 | 43216000 |
| Friday, January 1, 2016 | 19218000 | 50679000 |
| Sunday, January 1, 2017 | 27986000 | 79171000 |
| Monday, January 1, 2018 | 47928000 | 168218000 |
| Tuesday, January 1, 2019 | 96388000 | 210796000 |
| Wednesday, January 1, 2020 | 157743000 | 203613000 |
| Friday, January 1, 2021 | 195293000 | 234273000 |
| Saturday, January 1, 2022 | 237374000 | 265784000 |
| Sunday, January 1, 2023 | 295141000 | 344501000 |
| Monday, January 1, 2024 | 359272000 |
In pursuit of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial. Over the past decade, Insmed Incorporated and Blueprint Medicines Corporation have shown distinct patterns in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, peaking in 2023. Blueprint Medicines, while starting with lower expenses, saw a dramatic increase of nearly 3,600% during the same period. This growth reflects their strategic investments in research and market expansion. Notably, in 2023, Insmed's SG&A expenses were approximately 17% higher than Blueprint's, highlighting their aggressive market positioning. These trends underscore the competitive nature of the biotech industry, where financial agility can be as crucial as scientific innovation.
GSK plc and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Research and Development Expenses Breakdown: Insmed Incorporated vs Blueprint Medicines Corporation
Insmed Incorporated vs Halozyme Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Insmed Incorporated and Pharming Group N.V.
Insmed Incorporated and Opthea Limited: SG&A Spending Patterns Compared
Insmed Incorporated and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Blueprint Medicines Corporation
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Lantheus Holdings, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs ADMA Biologics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs Verona Pharma plc
Blueprint Medicines Corporation vs HUTCHMED (China) Limited: SG&A Expense Trends
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs Novavax, Inc.